By Paul F. Torrence
Drug discovery for influenza antivirals
Priorities for fighting pandemic influenza contain speedy detection and id, the short management of accessible medications to regard the an infection, the advance of latest antivirals, and the advance of vaccines. seeing that lead-time might be required to provide a good vaccine, antivirals could function a key first defensive position in containing an epidemic. various antivirals, appearing via various mechanisms, could aid remain the improvement of resistant viruses. therefore, drug discovery for influenza antivirals is a vital public health-related endeavor.
With chapters contributed by means of major foreign experts, this consultant will get readers in control at the most up-to-date advances and applied sciences in varied ways to drug discovery, covering:
present antivirals, together with widely potent anti-respiratory virus agents
the improvement of high-throughput screening assays
the improvement of nucleic acid-based antiviral drugs
Antiviral RNAi thoughts focusing on influenza virus
different promising antiviral drug discovery strategies
struggling with the specter of Pandemic Influenza: Drug Discovery methods consolidates the most recent info on assorted techniques into one complete source. it truly is a useful, hands-on reference for researchers in medicinal chemistry, pharmaceutical chemistry, drug discovery, biochemistry, virology, microbiology, and public health.Content:
Chapter 1 current Influenza Antivirals: Their Mechanisms of motion and capability within the Face of Avian Influenza (pages 1–37): Erik De Clercq
Chapter 2 improvement of High?Throughput Screening Assays for Influenza (pages 38–72): Diana L. Noah, E. Lucile White and James W. Noah
Chapter three Mechanisms of IFN Resistance by way of Influenza Virus (pages 73–97): Heather J. Ezelle and Bret A. Hassel
Chapter four largely powerful Anti?Respiratory Virus brokers (pages 98–125): Shiro Shigeta
Chapter five present prestige on improvement of Nucleic Acid?Based Antiviral medicinal drugs opposed to Influenza Virus an infection (pages 126–147): Jonathan P. Wong, Mary E. Christopher, Murray Cairns, L.?Q. sunlight, Roderic M. ok. Dale and Andres M. Salazar
Chapter 6 Antiviral RNA Interference concepts concentrating on Influenza Virus and different breathing Viruses (pages 148–165): Joost Haasnoot and Ben Berkhout
Chapter 7 Promising Antiviral Glyco?Molecules from an fit to be eaten Alga (pages 166–182): Toshimitsu Hayashi, Kyoko Hayashi, Kenji Kanekiyo, Yuko Ohta, Jung?Bum Lee, Minoru Hashimoto and Takahisa Nakano
Chapter eight Rational layout of an Anti?Adhesion Drug for Influenza (pages 183–208): Nicolai V. Bovin and Alexandra S. Gambaryan
Chapter nine figuring out Influenza Neuraminidase Inhibitors utilizing Quantitative Structure–Activity courting (QSAR) versions (pages 209–225): Rajeshwar P. Verma and Corwin Hansch
Chapter 10 Peptide Inhibitors concentrating on Virus?Cell Fusion at school I Enveloped Viruses (pages 226–246): George F. Gao
Chapter eleven Novel Influenza Therapeutics (pages 247–264): Laura M. Aschenbrenner, Nicole Pelletier, Mang Yu and Fang Fang
Read Online or Download Combating the Threat of Pandemic Influenza: Drug Discovery Approaches PDF
Best viral books
Greater than 50 medical circumstances assist you ace pathology classes and the USMLE
The Case records sequence is an award-winning studying procedure confirmed to enhance examination rankings. This sequence enables you to research within the context of genuine sufferers rather than easily memorizing. Case records: Pathology: moment version provides 50+ scientific circumstances with open-ended questions which weave easy technology strategies into the medical situation. each one case contains a longer dialogue (including definitions and a pathophysiology discussion), key issues, and 3-5 USMLE-style comprehension questions. The authors are skilled lecturers from the college of Texas-Houston clinical college and East Tennessee kingdom collage Quillen collage of drugs.
Proteases are enzymes that primarily "eat" protein. with out proteases, infectious organisms can't competently mount an assault opposed to a number. it's therefore that proteases became well known objectives for drug discovery. learn has proven that in case you can inhibit the protease, you could guard opposed to the invading microbe.
This ebook addresses the necessity for greater diagnostic and therapy guidance for sufferers in whom overall knee arthroplasty (TKA) has had an unsatisfactory consequence. It opens by means of discussing the fundamentals of TKA and a few of the explanations of failure and ache. Diagnostic elements are thought of intimately, with cognizance to advances in medical research, laboratory research and particularly, imaging options.
- Plague and Other Yersinia Infections
- Poliovirus: Methods and Protocols
- Meyler's Side Effects of Antimicrobial Drugs
- Phytothérapie anti-infectieuse
- Evidence-based Pediatric Infectious Diseases
- Infectious Diseases Emergencies
Additional info for Combating the Threat of Pandemic Influenza: Drug Discovery Approaches
De Clercq, E. Heterocyclic rimantadine analogues with antiviral activity. Bioorg. Med. Chem. 2003, 11, 5485–5492. 28 EXISTING INFLUENZA ANTIVIRALS 22. ; Foscolos, G. ; Kolocouris, N. Heterocyclic rimantadine analogues with antiviral activity. Bioorg. Med. Chem. 2006, 14, 3341–3348. 23. Belshe, R. ; Smith, M. ; Hall, C. ; Hay, A. J. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J. Virol. 1988, 62, 1508–1512. 24. Hayden, F. G. Antiviral resistance in influenza viruses—Implications for management and pandemic response.
Hamblin, J. ; Hart, G. ; Inglis, G. ; Jones, H. ; McConnell, D. ; Mason, A. ; Owens, I. ; Reece, P. ; Shanahan, S. ; Wu, W. ; Tucker, S. P. Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen. Antimicrob. Agents Chemother. 2004, 48, 4542–4549. 87. Sidwell, R. ; Huffman, J. ; Khare, G. ; Allen, L. ; Witkowski, J. ; Robins, R. K. Broad-spectrum antiviral activity of virazole: 1-β-Dribofuranosyl-1,2,4-triazole-3-carboxamide. Science 1972, 177, 705–706.
Dis. 2006, 193, 1626–129. 29. Shea, K. M. Shift shown in influenza A adamantane resistance. JAMA 2006, 296, 1585–1587. 30. De Clercq, E. Antivirals and antiviral strategies. Nature Rev. Microbiol. 2004, 2, 704–720. 31. Moscona, A. Neuraminidase inhibitors for influenza. N. Engl. J. Med. 2005, 353, 1363–1373. 32. Matrosovich, M. ; Matrosovich, T. ; Roberts, N. -D. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J. Virol. 2004, 78, 12665–12667.